| [1] |
Watanabe T, Minaga K, Kamata K, et al. Mechanistic insights into autoimmune pancreatitis and IgG4-related disease[J]. Trends Immunol, 2018, 39(11):874-889.
|
| [2] |
Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease?[J]. Am J Dig Dis, 1961(6):688-698.
|
| [3] |
Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease[J]. J Gastroenterol, 2003, 38(10):982-984.
URL
|
| [4] |
Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40(3):352-358.
URL
|
| [5] |
Tsen A, Alishahi Y, Rosenkranz L. Autoimmune pancreatitis and inflammatory bowel disease: an updated review[J]. J Clin Gastroenterol, 2017, 51(3):208-214.
|
| [6] |
Islam AD, Selmi C, Datta-Mitra A, et al. The changing faces of IgG4-related disease: clinical manifestations and pathogenesis[J]. Autoimmun Rev, 2015, 14(10):914-922.
|
| [7] |
Akiyama M. The call for considering follicular helper T cells in IgG4-related disease[J]. J Allergy Clin Immunol, 2018, 141(5):1958.
|
| [8] |
Fukui Y, Uchida K, Sakaguchi Y, et al. Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis[J]. J Gastroenterol, 2015, 50(4):435-444.
|
| [9] |
Oguchi T, Ota M, Ito T, et al. Investigation of susceptibility genes triggering lachrymal/salivary gland lesion complications in Japanese patients with type 1 autoimmune pancreatitis[J]. PLoS One, 2015, 10(5):e0127078.
|
| [10] |
Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?[J]. J Cell Mol Med, 2005, 9(3):741-744.
|
| [11] |
de Pretis N, de Marchi G, Frulloni L. Diagnosis and treatment of autoimmune pancreatitis[J]. Curr Opin Gastroenterol, 2018, 34(5):362-366.
|
| [12] |
van Heerde MJ, Buijs J, Hansen BE, et al. Serum level of Ca19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma[J]. Dig Dis Sci, 2014, 59(6):1322-1329.
|
| [13] |
Zhang J, Jia G, Zuo C, et al. (18)F-FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer[J]. BMC Cancer, 2017, 17(1):695.
|
| [14] |
Okazaki K, Chari ST, Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis[J]. Pancreatology, 2017, 17(1):1-6.
|
| [15] |
Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 Ⅲ. treatment and prognosis of autoimmune pancreatitis[J]. J Gastroenterol, 2014, 49(6):961-970.
URL
|
| [16] |
Masamune A, Nishimori I, Kikuta K, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis[J]. Gut, 2017, 66(3):487-494.
|
| [17] |
Nagpal SJS, Sharma A, Chari ST. Autoimmune pancreatitis[J]. Am J Gastroenterol, 2018, 113(9):1301.
|
| [18] |
Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience[J]. Gut, 2013, 62(11):1607-1615.
URL
|
| [19] |
Meng Q, Xin L, Liu W, et al. Diagnosis and treatment of autoimmune pancreatitis in China: a systematic review[J]. PLoS One, 2015, 10(6):e0130466.
|
| [20] |
Schneider A, Hirth M, Münch M, et al. Risk of cancer in patients with autoimmune pancreatitis: a single-center experience from Germany[J]. Digestion, 2017, 95(2):172-180.
|
| [21] |
Madhani K, Farrell JJ. Autoimmune pancreatitis: an update on diagnosis and management[J]. Gastroenterol Clin North Am, 2016, 45(1):29-43.
|
| [22] |
Liu Q, Niu Z, Li Y, et al. Immunoglobulin G4 (IgG4)-positive plasma cell infiltration is associated with the clinicopathologic traits and prognosis of pancreatic cancer after curative resection[J]. Cancer Immunol Immunother, 2016, 65(8):931-940.
|
| [23] |
Miyatani K, Saito H, Murakami Y, et al. A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis[J]. Virchows Arch, 2016, 468(5): 549-557.
|